Charles Maynard

Impact of Dapagliflozin on MRI ‐Derived Epicardial Adipose Tissue: Secondary Imaging Analysis of a Randomized Trial

BACKGROUND: Epicardial adipose tissue (EAT) is a metabolically active fat depot associated with cardiovascular risk and represents a modifiable imaging biomarker. Studies have shown that sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce EAT thickness in patients with type...